Royal Bank of Canada’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.95M | Buy |
121,946
+120,464
| +8,128% | +$1.93M | ﹤0.01% | 3048 |
|
|
2025
Q1 | $23K | Sell |
1,482
-1,752
| -54% | -$27.2K | ﹤0.01% | 5491 |
|
|
2024
Q4 | $66K | Buy |
3,234
+790
| +32% | +$16.1K | ﹤0.01% | 5081 |
|
|
2024
Q3 | $63K | Buy |
2,444
+4
| +0.2% | +$103 | ﹤0.01% | 5133 |
|
|
2024
Q2 | $31K | Buy |
+2,440
| New | +$31K | ﹤0.01% | 5490 |
|
|
2023
Q3 | – | Sell |
-344
| Closed | -$10K | – | 7004 |
|
|
2023
Q2 | $10K | Buy |
344
+215
| +167% | +$6.25K | ﹤0.01% | 6030 |
|
|
2023
Q1 | $2K | Sell |
129
-232
| -64% | -$3.6K | ﹤0.01% | 6409 |
|
|
2022
Q4 | $4K | Buy |
361
+333
| +1,189% | +$3.69K | ﹤0.01% | 6328 |
|
|
2022
Q3 | $1K | Buy |
28
+15
| +115% | +$536 | ﹤0.01% | 6783 |
|
|
2022
Q2 | $1K | Sell |
13
-118
| -90% | -$9.08K | ﹤0.01% | 6742 |
|
|
2022
Q1 | $13K | Sell |
131
-336
| -72% | -$33.3K | ﹤0.01% | 6356 |
|
|
2021
Q4 | $72K | Buy |
467
+374
| +402% | +$57.7K | ﹤0.01% | 5631 |
|
|
2021
Q3 | $12K | Buy |
93
+32
| +52% | +$4.13K | ﹤0.01% | 6383 |
|
|
2021
Q2 | $9K | Buy |
+61
| New | +$9K | ﹤0.01% | 6415 |
|